TXMD logo

TherapeuticsMD (TXMD)

Profile

Full Name

TherapeuticsMD, Inc.

Ticker Symbol

TXMD

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

IPO

May 9, 2007

Indexes

Not included

Website

http://www.therapeuticsmd.com

Employees

1

Key Details

Price

$1.00(+1.52%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.76M(+35.25% YoY)

Annual EPS

-$0.19(+80.61% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.00
TXMD price is $1.00

30-Day Relative Volume

0.51
TXMD 30-day relative volume is 0.51

Price Performance

Price Today change

+1.52%
TXMD price is up +1.52% today

Price YTD change

+16.86%
TXMD price is up +16.86% since January 1st

Price 1-year change

-49.5%
TXMD price is down -49.5% year-on-year

Price 3-year change

-93.07%
TXMD price is down -93.07% over the past 3 years

Price Range

Price All-time high

$8000.00
TXMD price is currently -99.99% below its historical high of $8000.00

Price 3-year low

$0.70
TXMD price is currently +43.57% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$11.59M
TXMD market capitalization is $11.59 million

Market cap 3-year change

-90.78%
TXMD market capitalization is down -90.78% over the past 3 years

Market cap All-time high

$1.96B
TXMD market capitalization is currently -99.41% below its historical high of $1.96 billion

Market cap sector rank

21.77%
TXMD market capitalization is higher than 21.77% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

0%
TXMD {parameterFullLabel} has remained unchanged year-on-year

Shares Outstanding 3-Year Change

+33.03%
TXMD shares outstanding is up +33.03% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.53
TXMD beta is 0.53

200-day SMA

$1.37
TXMD price is currently -26.82% below its 200-day simple moving average

50-day SMA

$0.93
TXMD price is currently +8.04% above its 50-day simple moving average

RSI

56.33
TXMD 14-day relative strength index is 56.33

Volume

0.51
TXMD 30-day relative volume is 0.51

ATR

$0.10
TXMD average true range is $0.10

10-day Historical Volatility

95.02%
TXMD 10-day historical volatility is 95.02%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.76M
TXMD annual revenue is $1.76 million

Revenue Analysts estimate

-
TXMD annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

+35.25%
TXMD annual revenue is up +35.25% year-on-year

Revenue Sector rank

14.56%
TXMD annual revenue is higher than 14.56% of companies in Healthcare sector

EPS

EPS

-$0.19
TXMD annual earnings per share is -$0.19

EPS Analysts estimate

-
TXMD annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+80.61%
TXMD annual earnings per share is up +80.61% year-on-year

EPS Sector rank

77.87%
TXMD annual earnings per share is higher than 77.87% of companies in Healthcare sector

Profit

Gross profit

-
TXMD annual gross profit value is unknown

Gross margin

-
TXMD annual gross profit margin value is unknown

Operating profit

-$3.49M
TXMD annual operating income is -$3.49 million

Operating margin

-198.30%
TXMD annual operating profit margin is -198.30%

Net income

-$2.18M
TXMD annual net profit is -$2.18 million

Net margin

-123.85%
TXMD annual net profit margin is -123.85%

Expenses

Total expenses

$5.25M
TXMD annual total expenses is $5.25 million

Operating expenses

$5.25M
TXMD annual total operating expenses is $5.25 million

Cost of goods sold

-
TXMD annual cost of goods sold value is unknown

Selling, general & administrative expenses

$4.74M
TXMD annual SGA is $4.74 million

Depreciation and amortization

$509.00K
TXMD annual depreciation & amortization is $509.00 thousand

Interest expense

-
TXMD annual interest expense value is unknown

Income tax

-$31.00K
TXMD annual income tax is -$31.00 thousand

EBIT & EBITDA

EBIT

-$3.49M
TXMD annual earnings before interest & taxes is -$3.49 million

EBITDA

-$2.98M
TXMD annual EBITDA is -$2.98 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$38.82M
TXMD annual total assets is $38.82 million

Non current assets

$26.56M
TXMD annual long term assets is $26.56 million

Current assets

$12.26M
TXMD annual total current assets is $12.26 million

Cash and cash equivalents

$5.06M
TXMD annual cash & cash equivalents is $5.06 million

Accounts receivable

-
TXMD annual accounts receivable value is unknown

Inventory

-
TXMD annual inventory value is unknown

Liabilities

Total liabilities

$11.45M
TXMD annual total liabilities is $11.45 million

Long term liabilities

$6.29M
TXMD annual total long term liabilities is $6.29 million

Current liabilities

$5.17M
TXMD annual total current liabilities is $5.17 million

Accounts payable

$258.00K
TXMD annual accounts payable is $258.00 thousand

Debt

Total debt

$7.17M
TXMD annual total debt is $7.17 million

Total debt 1-year change

-10.37%
TXMD annual total debt is down -10.37% year-on-year

Long term debt

$5.54M
TXMD annual long term debt is $5.54 million

Short term debt

$1.63M
TXMD annual short term debt is $1.63 million

Equity & Capital

Shareholders equity

$27.37M
TXMD annual stockholders equity is $27.37 million

Book value

$27.37M
TXMD annual book value is $27.37 million

Retained earnings

-$951.82M
TXMD annual retained earnings is -$951.82 million

Working capital

$7.09M
TXMD annual working capital is $7.09 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$1.17M
TXMD annual cash flow from operations is $1.17 million

Cash from operations 1-year change

+105.07%
TXMD annual cash flow from operations is up +105.07% year-on-year

Cash from investing

-
TXMD annual cash flow from investing activities value is unknown

Cash from investing 1-year change

-
TXMD annual cash flow from investing activities 1-year change is unknown

Cash from financing

$0.00
TXMD annual cash flow from financing activities is $0.00

Cash from financing 1-year change

-100%
TXMD annual cash flow from financing activities is down -100% year-on-year

CAPEX

CAPEX

-
TXMD annual capital expenditures value is unknown

CAPEX 1-year change

-
TXMD annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

$1.17M
TXMD annual free cash flow is $1.17 million

Free cash flow 1-year change

+105.07%
TXMD annual free cash flow is up +105.07% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
TXMD annual gross profit margin value is unknown

Operating margin

-198.30%
TXMD annual operating profit margin is -198.30%

Net margin

-123.85%
TXMD annual net profit margin is -123.85%

ROA & ROE

ROA

-5.31%
TXMD annual return on assets is -5.31%

ROE

-7.70%
TXMD annual return on equity is -7.70%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
TXMD price to earnings ratio value is unknown

PE ratio Sector rank

-
TXMD price to earnings ratio is unknown

PB Ratio

PB ratio

0.42
TXMD price to book ratio is 0.42

PB ratio Sector rank

27.38%
TXMD price to book ratio is higher than 27.38% of companies in Healthcare sector

PS Ratio

PS ratio

6.58
TXMD price to sales ratio is 6.58

PS ratio Sector rank

71.92%
TXMD price to sales ratio is higher than 71.92% of companies in Healthcare sector

Enterprise value

Enterprise value

$13.71M
TXMD enterprise value is $13.71 million

Enterprise value Sector rank

28.74%
TXMD enterprise value is higher than 28.74% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-4.59
TXMD EV/EBITDA is -4.59

EV/EBITDA Sector rank

19.64%
TXMD EV/EBITDA is higher than 19.64% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.37
TXMD annual current ratio is 2.37

Quick ratio

-
TXMD annual quick ratio value is unknown

Leverage

Debt to equity

0.00
TXMD annual debt to equity ratio is 0.00

Interest coverage ratio

-
TXMD annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
TXMD piotroski f-score value is unknown

Altman Z-Score

-33.75
TXMD altman z-score is -33.75

Analyst ratings

Recent major analysts updates

Aug 17, 23 Cantor Fitzgerald
Neutral
Jul 13, 22 Cantor Fitzgerald
Neutral
Jun 7, 22 HC Wainwright & Co.
Neutral
May 6, 22 Cantor Fitzgerald
Neutral
Mar 11, 22 HC Wainwright & Co.
Buy
Nov 12, 21 HC Wainwright & Co.
Buy
Aug 7, 20 Jefferies
Underperform
May 19, 20 JP Morgan
Neutral
May 7, 20 H.C. Wainwright
Buy
Apr 16, 20 Stifel
Buy

Institutional Ownership

Similar stocks

ICU logo
SeaStar Medical Holding (ICU)
SABS logo
SAB Biotherapeutics (SABS)
ABVC logo
ABVC BioPharma (ABVC)
PAVM logo
PAVmed (PAVM)
TRIB logo
Trinity Biotech (TRIB)
PETV logo
PetVivo Holdings (PETV)
CODX logo
Co-Diagnostics (CODX)
Adagio Medical Holdings (ADGM)
MRKR logo
Marker Therapeutics (MRKR)
  • What is the ticker symbol for TherapeuticsMD?
  • Does TherapeuticsMD pay dividends?
  • What sector is TherapeuticsMD in?
  • What industry is TherapeuticsMD in?
  • What country is TherapeuticsMD based in?
  • When did TherapeuticsMD go public?
  • Is TherapeuticsMD in the S&P 500?
  • Is TherapeuticsMD in the NASDAQ 100?
  • Is TherapeuticsMD in the Dow Jones?
  • When was TherapeuticsMD's last earnings report?
  • When does TherapeuticsMD report earnings?
  • Should I buy TherapeuticsMD stock now?

What is the ticker symbol for TherapeuticsMD?

The ticker symbol for TherapeuticsMD is NASDAQ:TXMD

Does TherapeuticsMD pay dividends?

No, TherapeuticsMD does not pay dividends

What sector is TherapeuticsMD in?

TherapeuticsMD is in the Healthcare sector

What industry is TherapeuticsMD in?

TherapeuticsMD is in the Drug Manufacturers - Specialty & Generic industry

What country is TherapeuticsMD based in?

TherapeuticsMD is headquartered in United States

When did TherapeuticsMD go public?

TherapeuticsMD's initial public offering (IPO) was on May 9, 2007

Is TherapeuticsMD in the S&P 500?

No, TherapeuticsMD is not included in the S&P 500 index

Is TherapeuticsMD in the NASDAQ 100?

No, TherapeuticsMD is not included in the NASDAQ 100 index

Is TherapeuticsMD in the Dow Jones?

No, TherapeuticsMD is not included in the Dow Jones index

When was TherapeuticsMD's last earnings report?

TherapeuticsMD's most recent earnings report was on Mar 27, 2025

When does TherapeuticsMD report earnings?

The next expected earnings date for TherapeuticsMD is May 9, 2025

Should I buy TherapeuticsMD stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page